NOVONIX Faces US$7M Cash Amortisation on Yorkville Debentures as Share Price Breaks Floor

summarizeSummary

NOVONIX must pay US$7 million in cash to Yorkville by 21 September after its share price fell below the A$0.12 floor price, with further 20% amortisation payments due every 30 days while the price stays below the floor. Lead customer C-sample testing met 12 of 14 specs, with mass production sales still targeted for H2 2027.

check_boxKey Events · Financing and Capital Events · NVX

• Amortisation Event Triggered

  ASX VWAP fell below the A$0.12 floor price in the Yorkville convertible debenture agreement, triggering a mandatory cash redemption of US$7,000,000 (20% of the US$35,000,000 outstanding) due by 21 September 2026.

• Rolling Cash Drain Risk

  If the share price remains below the floor, the company must pay a further 20% of the outstanding amount every 30 days until the floor is regained or the debentures are fully repaid — a recurring cash obligation tied directly to share price weakness.

• Liquidity Pressure

  The US$7 million payment will be funded from existing cash reserves, which stood at US$59.5 million as of 30 July 2026. The company is already under a going concern warning from its auditor, and the amortisation schedule adds a new, price-sensitive cash outflow.

• Customer Qualification Progress

  Lead customer C-sample testing of synthetic graphite anode material met 12 of 14 specification parameters. One miss was within ~1% of the requirement; the other was assessed on a pass/fail basis. NOVONIX's internal testing indicated all specs were met.

auto_awesomeAnalysis · NVX · Manufacturing

A drop in NOVONIX's ASX share price below the A$0.12 floor price in its Yorkville convertible debenture agreement has triggered a mandatory US$7 million cash redemption due by 21 September 2026. This represents a material cash outflow for a company that reported only US$59.5 million in cash at the end of July and is already under a going concern warning from its auditor. The amortisation obligation is not a one-off: if the share price stays below the floor, the company must pay another 20% of the outstanding balance every 30 days, creating a rolling cash drain that could accelerate liquidity pressure. The company says it will fund the payment from existing cash reserves, but the recurring nature of the obligation means the balance sheet is now directly exposed to share price weakness. Separately, the lead customer's C-sample testing met 12 of 14 specifications, a step forward in qualification but not yet a pass — the company still expects mass production sales only in H2 2027, leaving a long runway before this customer generates revenue.